1UMW image
Entry Detail
PDB ID:
1UMW
Keywords:
Title:
Structure of a human Plk1 Polo-box domain/phosphopeptide complex
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2003-08-29
Release Date:
2003-10-16
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.26
R-Value Work:
0.23
R-Value Observed:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:SERINE/THREONINE-PROTEIN KINASE PLK
Chain IDs:A, B
Chain Length:237
Number of Molecules:2
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Description:PEPTIDE
Chain IDs:C (auth: E), D (auth: F)
Chain Length:7
Number of Molecules:2
Biological Source:SYNTHETIC CONSTRUCT
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
TPO C THR PHOSPHOTHREONINE
Primary Citation
The Molecular Basis for Phosphodependent Substrate Targeting and Regulation of Plks by the Polo-Box Domain
Cell(Cambridge,Mass.) 115 83 ? (2003)
PMID: 14532005 DOI: 10.1016/S0092-8674(03)00725-6

Abstact

Polo-like kinases (Plks) perform crucial functions in cell-cycle progression and multiple stages of mitosis. Plks are characterized by a C-terminal noncatalytic region containing two tandem Polo boxes, termed the Polo-box domain (PBD), which has recently been implicated in phosphodependent substrate targeting. We show that the PBDs of human, Xenopus, and yeast Plks all recognize similar phosphoserine/threonine-containing motifs. The 1.9 A X-ray structure of a human Plk1 PBD-phosphopeptide complex shows that the Polo boxes each comprise beta6alpha structures that associate to form a 12-stranded beta sandwich domain. The phosphopeptide binds along a conserved, positively charged cleft located at the edge of the Polo-box interface. Mutations that specifically disrupt phosphodependent interactions abolish cell-cycle-dependent localization and provide compelling phenotypic evidence that PBD-phospholigand binding is necessary for proper mitotic progression. In addition, phosphopeptide binding to the PBD stimulates kinase activity in full-length Plk1, suggesting a conformational switching mechanism for Plk regulation and a dual functionality for the PBD.

Legend

Protein

Chemical

Disease

Primary Citation of related structures